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Gut microbe-derived extracellular 
vesicles induce insulin resistance, 
thereby impairing glucose 
metabolism in skeletal muscle
Youngwoo Choi1, Yonghoon Kwon1, Dae-Kyum Kim1, Jinseong Jeon1, Su Chul Jang1, 
Taejun Wang2, Minjee Ban1, Min-Hye Kim3, Seong Gyu Jeon1, Min-Sun Kim4, Cheol Soo 
Choi5, Young-Koo Jee6, Yong Song Gho1, Sung Ho Ryu1 & Yoon-Keun Kim3
Gut microbes might influence host metabolic homeostasis and contribute to the pathogenesis of type 
2 diabetes (T2D), which is characterized by insulin resistance. Bacteria-derived extracellular vesicles 
(EVs) have been suggested to be important in the pathogenesis of diseases once believed to be non-
infectious. Here, we hypothesize that gut microbe-derived EVs are important in the pathogenesis of 
T2D. In vivo administration of stool EVs from high fat diet (HFD)-fed mice induced insulin resistance 
and glucose intolerance compared to regular diet (RD)-fed mice. Metagenomic profiling of stool EVs 
by 16S ribosomal DNA sequencing revealed an increased amount of EVs derived from Pseudomonas 
panacis (phylum Proteobacteria) in HFD mice compared to RD mice. Interestingly, P. panacis EVs 
blocked the insulin signaling pathway in both skeletal muscle and adipose tissue. Moreover, isolated 
P. panacis EVs induced typical diabetic phenotypes, such as glucose intolerance after glucose 
administration or systemic insulin injection. Thus, gut microbe-derived EVs might be key players in 
the development of insulin resistance and impairment of glucose metabolism promoted by HFD.
Coelomate animals possess an internal body cavity surrounding the gut and other organs and have 
coevolved with a diverse range of symbiotic gut microbes collectively known as the gut microbiota1. The 
gut microbiota is involved in the regulation of systemic immune responses, and influence multiple host 
metabolism2–4. The increased incidence of gut dysbiosis (an imbalance in the gut microbes leading to 
disease) in westernized countries over several decades is associated with metabolic diseases such as obe-
sity and type 2 diabetes (T2D)5–8. T2D, one of the most well-known carbohydrate metabolism disorders, 
accounts for almost 90% of adult diabetes cases and is characterized by insulin resistance and low-grade 
inflammation9–12. Although commensal gut microbes have been implicated in the pathogenesis of T2D 
promoted by a high fat diet (HFD), the mechanism underlying this phenomenon is still unclear.
Host and gut microbes coproduce a large array of materials during the metabolism of food, many 
of which play critical roles in shuttling information between host cells and the microbes. Extracellular 
vesicles (EVs) were found about 30 years ago when EVs in multivesicular bodies were observed in retic-
ulocytes and released into the extracellular space13,14. It is now known that both bacterial and eukaryotic 
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cells release EVs as a means of intercellular communication, thereby influencing neighboring and distant 
cells15–17. Bacteria-derived EVs, also called nanovesicles, are spherical bi-layered phospholipids with diam-
eters ranging from 20 to 100 nm. Nanovesicles are produced ubiquitously by all gram-negative bacteria 
and also by some gram-positive bacteria18,19. Previous biochemical studies revealed that gram-negative 
bacteria-derived EVs are composed of outer membrane proteins, lipopolysaccharide (LPS), outer mem-
brane lipids, periplasmic proteins, DNA, RNA, and other factors associated with virulence18. The role of 
infectious agents in the etiology of diseases once believed to be non-infectious is increasingly being rec-
ognized20. As a candidate for the causative agents of these diseases, our previous studies have shown that 
EVs from indoor dust and from gram-positive bacteria induce neutrophilic pulmonary inflammation21,22.
In this study, we hypothesized that EVs-mediated cross-talk between the host and gut microbiota may 
underlie the development of T2D in a fat-rich dietary regimen. Here, we showed that in vitro adminis-
tration of microbe-derived EVs induced insulin resistance including impairment of insulin signaling and 
decrease in GLUT4 translocation in myotubes. Moreover, these EVs also induced diabetic phenotypes in 
mice, such as glucose intolerance after glucose administration and insulin injection.
Methods
Mice. C57BL/6J (6–8-wk-old) mice from the Jackson Laboratory were used. All animal experiments 
were approved by POTECH Animal Use and Care Committee (Permit Number: 2012-01-0020) and per-
formed in accordance with the Guide for the Care and Use of Laboratory Animals published by Animal 
and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs, Korea.
Isolation of stool EVs. We placed each group of mice on an RD, or an HFD containing 60% fat for 
12 weeks and collected stool samples at 12 weeks. Stool samples were dissolved in Phosphate Buffered 
Saline (PBS) and centrifuged at 5, 20, and 340 g for 5 min each. Supernatant fractions were pelleted 
once at 10,000 g for 30 min and then filtered through a 0.45-μ m syringe filter (Sartorius Stedim Biotech, 
Goettingen, Germany) followed filtration through a 0.22-μ m syringe filter (Sartorius Stedim Biotech, 
Goettingen, Germany). The filtrates were then subjected to density-gradient centrifugation in a Beckman 
ultracentrifuge (Beckman Coulter, Fullerton, USA) at 100,000 g for 2 h at 4 °C. Fraction between 10% and 
40% OptiPrep solution (Sigma, St. Louis, USA) was taken, and EVs were prepared by centrifugation at 
150,000 g for 2 h at 4 °C using a Beckman ultracentrifuge. EVs were diluted in PBS and stored at –80 °C. 
The protein concentration of EVs was assessed by a BCA assay (Thermo Fisher Scientific, Waltham, 
USA).
Preparation of bacterial EVs. Bacterial EVs were prepared as described previously18. P. cedrina was 
grown at 30 °C and P. panacis at 25 °C in Luria-Bertani broth. Culture media were pelleted twice at 
10,000 g for 30 min. Supernatant fractions were filtered through a 0.45-μ m bottle-top filter (Sigma, St. 
Louis, USA), and the eluted samples were enriched using QuixStand™ (GE Healthcare, Little Chalfont, 
UK). Concentrated samples were subsequently filtered through a 0.22-μ m bottle-top filter (Sigma, St. 
Louis, USA). The filtrates were then subjected to centrifugation in a Beckman ultracentrifuge at 150,000 g 
for 2 h at 4 °C. The protein concentration of EVs was assessed by a BCA assay (Thermo Fisher Scientific, 
Waltham, USA).
Transmission electron microscopy. EVs (50 μ g/mL of total protein) were placed on 300-mesh cop-
per grids (Electron Microscopy Sciences, Hatfield, USA) and stained with 2% uranyl acetate for 12 h. 
Images were obtained by using a JEM1011 microscope (JEOL, Akishima, Japan) at an accelerating volt-
age of 100 kV.
Dynamic light scattering. Diameter of EVs (5 μ g/mL of total protein) was measured by using a 
Zetasizer Nano S (Malvern Instruments, Malvern, UK) equipped with a 633-nm laser line at a scattered 
intensity of 10 × 30 s.
Detection of lipopolysaccharide (LPS) and lipoteichoic acid (LTA). LPS and LTA were detected 
by using primary antibodies against lipid A (Abcam, Eugene, USA) and lipoteichoic acid (Abcam, 
Eugene, USA).
DNA extraction, bacterial 16S rDNA gene amplification and pyrosequencing analysis. DNA 
was extracted from bacteria and EVs in stools using a stool DNA extraction kit (Bioneer, Daejeon, 
Korea). Bacterial genomic DNA was amplified with 27F (5′ -AGAGTTTGATCCTGGCTCAG-3′ ) and 
518R (5′ -ATTACCGCGGCTGCTGG-3′ ) primers, which are specific for V1-V3 hypervariable regions 
of 16S rDNA gene. The libraries were prepared using PCR products according to the GS FLX titanium 
library prep guide and quantified using a Picogreen assay (Invitrogen, Waltham, USA). After PCR prod-
ucts extracted and quantified, equimolar ratios from each mixture were pooled and sequenced on a 454 
Life Sciences Genome Sequencer FLX system (Roche, Basel, Switzerland) according to the manufacturer’s 
recommendations.
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Taxonomic assignment. Raw pyrosequencing reads obtained from the sequencer were filtered accord-
ing to the barcode and primer sequences using sffinfo script (Roche, Basel, Switzerland). Preliminary 
quality control steps included the removal of sequences shorter than 300 nt. To select 16S rDNAs, all 
the sequence reads were compared to the EzTaxon database23,24 by BLASTN25. Sequence reads that had 
a similar sequence with more than 100 bit score and less than 1.0 E-value were admitted as partial 16S 
rDNA sequences. Taxonomy-based analyses were performed using EzTaxon. From the database, five of 
the most similar sequences for each sequence read were found by their bit scores by using the BLASTN 
program. Among these five sequences, similarity with the sequence read was calculated by ClustalW26, 
and the taxonomy of sequences with the highest similarity was assigned to the sequence read.
L6 myotubes culture. L6 myotubes were differentiated and cultured as described previously27. L6 
myotubes were grown in Alpha Minimum Essential Medium (α -MEM) containing 10% fetal bovine 
serum (FBS) and 1% penicillinstreptomycin at 37 °C, 5% CO2 in a humidified incubator. Differentiation 
of L6 myotubes was induced by incubation in 2% FBS containing α -MEM for 1 week.
3T3-L1 adipocytes culture. The 3T3-L1 pre-adipocyte cell line was maintained in Dulbecco’s 
Modified Eagle’s Medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillinstrepto-
mycin. The procedure of adipocyte differentiation was performed as described previously28.
Analysis of the insulin signaling pathway. To prepare total cell lysates, plated cells were lysed 
with lysis buffer containing 40 mM HEPES, 120 mM NaCl, 1 mM EDTA, 10 mM pyrophosphate, 10 mM 
glycerophosphate, 50 mM NaF, 1.5 mM Na3VO4, 1 mM PMSF, 5 mM MgCl2, 0.5% Triton X-100, and 
protease inhibitor mixture. Following SDS-PAGE and transfer to a nitrocellulose membrane, each molec-
ular size of nitrocellulose membrane was incubated with primary antibodies (1:1000) overnight at 4 °C. 
For evaluation of the insulin signaling pathway, the following antibodies were used: anti-tIRS1 (EMD 
Millipore, Billerica, USA), anti-pIRS1 (Cell Signaling Technology, Danvers, USA), anti-tAKT (Santa 
Cruz Biotechnology, Dallas, USA), anti-pAKT (Cell Signaling Technology, Danvers, USA), and anti-actin 
(MP Biochemicals, Santa Ana, USA).
Glucose uptake measurement. 2-Deoxyglucose uptake was determined as described previously29. 
L6 myotubes were serum starved for 2 h before treatment with EVs (10 μ g of total protein) for 4 h. The 
medium was replaced with 1 mL of Kreb’s buffer and cells were stimulated with 5 nM insulin for 10 min 
at 37 °C. Glucose uptake was measured by adding 0.1 mCi/mL of 2-deoxy[14C]glucose (final concentra-
tion: 0.1 mM). After 10 min, assays were terminated by washing with cold PBS twice. Cells were lysed 
in 0.5 mL of lysis buffer containing 0.5 N NaOH and 0.1% SDS, and cell lysates were subjected to liquid 
scintillation counting.
o-Phenylenediamine dihydrochloride (OPD) assay. A colorimetric assay of surface GLUT4myc 
was performed using the anti-Myc antibody (1:100) as described previously30. EVs (10 μ g of total protein) 
were administrated to L6 myotubes for 4 h following 2 h of serum starvation. The cells were washed once 
with PBS and then incubated with anti-Myc antibody (EMD Millipore, Billerica, USA). After incuba-
tion with the primary antibody, peroxidase-conjugated rabbit anti-mouse IgG (1:1000) was added for 
30 min at 4 °C. The cells were washed and 1 mL of OPD reagent was added. The colorimetric reaction 
was stopped by adding 0.25 mL of 3N HCl. After 10 min, the optical absorbance of the supernatant was 
measured at 492 nm.
In vivo metabolic studies. EVs (1 μ g of total protein) were orally administered once every 2 days 
for 1 month. For the glucose tolerance test (GTT), mice were initially fasted for 12 h. Then, 1 gram of 
dextrose (Sigma, St. Louis, USA) per kilogram body weight was administered intraperitoneally, and 
blood glucose concentrations were subsequently measured at the indicated time points. For the insulin 
tolerance test (ITT), the mice were fasted for 6 h, followed by intraperitoneal injection of 0.5U insulin 
(Sigma, St. Louis, USA) per kilogram body weight. Blood glucose concentrations were measured at indi-
cated time points using a glucometer (Abbott Diabetes Care, Alameda, USA.). The blood used for both 
GTT and ITT was withdrawn from the tail vein of mice.
In vivo fluorescent imaging. Bacteria or bacterial EVs were incubated with 5 μ M Cy7 mono NHS 
ester (GE Healthcare, Little Chalfont, UK) for 1 h at 37 °C. Cy7 mono NHS ester-labbeled samples were 
isolated using ultracentrifugation. Then, bacteria or bacterial EVs (20 μ g of total protein) were adminis-
tered by gavage to each mouse that had been fasted overnight. At the indicated time point, whole body 
images were obtained at 780–800 nm wavelength using IVIS® spectrum CT (SelectScience, Wilmslow, 
UK). After 12 h, the mice were sacrificed and Cy7 fluorescence was quantified in tissues including the 
liver, fat, and muscle.
Two-photon microscopy. P. panacis-derived EVs were incubated with 5–10 μ M DiO (Invitrogen, 
Waltham, USA) for 30 min at 37 °C. The mice were fasted overnight and the large intestines were pulled 
out. Both sides of the large intestine were sealed, and then fluorescent-labeled EVs (10 μ g of total protein) 
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were administered into the intestinal lumen. Images were taken 10 min after the application, by using a 
TCS SP5 microscope (Leica Microsystems, Wetzlar, Germany).
Immunohistochemistry. Extracted liver, adipose tissue, skeletal muscle, and large intestine were 
embedded in an OCT compound (Sakura Finetek, Radnor, USA), frozen, and cut with a CM-3050S 
(Leica Microsystems, Wetzlar, Germany) into 0.2-μ m-thick sections. For the detection of EVs, blocking 
was performed using 0.05% horse serum. Primary antibodies (1:100) were diluted in blocking buffer and 
added to samples overnight at 4 °C. After three washes, GFP-conjugated secondary antibodies (1:5000) 
were added, and the sections were incubated for 1 h at 37 °C. Subsequently, 4′ ,6-diamidino-2-phenylindole 
(DAPI) staining was performed. Samples were then imaged using a TCS SP5 microscope (Leica 
Microsystems, Wetzlar, Germany).
Statistics. All statistical analyses consisted of unpaired, two-tailed Student’s t-tests using Excel 
(Microsoft, Redmond, USA), followed by Bonferroni’s post hoc test using GraphPad Prism5 (GraphPad 
Software, San Diego, USA). P < 0.05 was considered to be significant. All data are expressed as means ± SD.
Results
Characterization of stool EVs from HFD- and RD-fed mice. To assess changes in gut microbe-de-
rived EVs in response to a change in diet, mice were fed with HFD or RD for 12 weeks (Fig. 1A). EVs 
Figure 1. Insulin resistance and glucose intolerance are induced by stool EVs isolated from HFD-fed 
mice. (A) An experimental protocol for isolating stool EVs in HFD- and RD-fed mice. (B) Transmission 
electron microscopic (TEM) images of stool EVs (hEV vs. rEV). (C) Western blot data of insulin signaling 
molecules in L6 myotubes after treating stool EVs (hEV or rEV), with or without insulin (Ins). (D) 
2-Deoxy[14C]glucose uptake in L6 myotubes in response to stool EVs (hEV or rEV), with or without Ins 
treatment. *P < 0.05. (E) GLUT4 translocation to the membrane of L6 myotubes in response to stool EVs 
(hEV or rEV), with or without Ins. *P < 0.05. (F) Change of mouse body weight at the indicated day after 
the oral administration of stool EVs (hEV or rEV) (n = 8 mice per group). (G) Phosphorylation of IRS1 and 
AKT in skeletal muscle from hEV- or rEV-administered mice. *P < 0.05.
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were isolated from stools collected from the 2 groups, HFD or RD. The size of EVs from HFD-fed mice 
stools (hEV) showed drastic decrease from that of EVs from RD-fed mice stools (rEV) (Fig. 1B and S1A). 
Protein profiling evaluation showed that the protein pattern in hEV was different from rEV (Figure S1B). 
In addition, hEV had more LPS, but less LTA vs. rEV (Figure S1C). These findings suggest that a change 
in diet from RD to HFD regimen resulted in a change in the characteristics of gut microbial EVs.
In vitro effects of stool EVs enhanced by HFD on the insulin signaling and glucose metabo-
lism. To evaluate the in vitro effects of gut microbial EVs on the insulin resistance, skeletal muscle cells 
(myotubes) were treated with hEV and rEV, with and without insulin. The expression of phosphorylated 
AKT (pAKT), which enhanced by insulin treatment, was inhibited in myotubes by the treatment of 
hEV vs. rEV (Fig. 1C). Furthermore, insulin-stimulated glucose uptake by these cells was also decreased 
by hEV treatment as compared to rEV treatment (Fig.  1D). In addition, an in vitro assay after insulin 
stimulation displayed the blunted increase in GLUT4 translocation to the membrane of myotubes treated 
with hEV vs. rEV (Fig. 1E). Taken together, these findings suggest that EVs enhanced by HFD interfere 
with insulin signaling and impair glucose uptake in skeletal muscle.
In vivo effects of stool EVs enhanced by HFD on the insulin signaling and glucose metabo-
lism. To address the in vivo effects of EVs from HFD-fed mice stools on the glucose metabolism, EVs, 
isolated 12 weeks after the initiation of HFD, were administered orally, and then insulin and glucose 
tolerance tests were performed. This study showed that body weight gain was blunted in mice admin-
istered with hEV compared to rEV (Fig.  1F). In addition, the decline of blood glucose after glucose 
administration and after insulin injection was blunted in hEV-administered mice vs. rEV-administered 
mice (Figure S2). Furthermore, the expression of pAKT in skeletal muscle was decreased in hEV-treated 
mice compared to rEV-treated mice (Fig. 1G). Collectively, these findings indicate that EVs enhanced by 
HFD can induce insulin resistance and glucose intolerance in murine skeletal muscle.
Compositional changes of bacteria and bacteria-derived EVs in stools according to diet change. 
The composition of gut microbes and gut microbe-derived EVs in stools were evaluated using 16S rDNA 
sequencing in mice fed with HFD or RD, as a control, 12 weeks after the initiation of HFD. The com-
position of bacteria and bacterial EVs was profiled at the levels of phylum, class, order, family, genus, 
and species (Tables S1–S3 and Figure S3). In agreement with a previous report31, HFD induced a change 
in bacterial composition at the phylum level, primarily an increase in Firmicutes and Proteobacteria, 
and a decrease in Bacteroidetes. Notably, the composition of bacterial EVs differed from that of bac-
teria (Fig.  2A). Diet change from RD to HFD induced more drastic changes in the composition of 
gut-microbial EVs vs. gut microbes (Fig. 2B). To select candidate EVs, as a cause of T2D promoted by 
HFD, data from 16S rDNA sequencing were filtered by four sequential steps, as shown in Fig. 2C. This 
study showed that the composition of P. panacis-derived EVs dramatically increased by HFD and were 
selected as a candidate causative agent, whereas that of P. cedrina-derived EVs decreased and selected as 
a control (Fig. 2D).
Characterization of EVs derived from P. cedrina and P. panacis. To characterize EVs from P. 
cedrina and P. panacis, we cultured these two bacteria, and isolated EVs from the culture supernatants 
of culture media. The present study showed that P. cedrina- and P. panacis-derived EVs were spherical 
in shape (Fig.  3A), and the size of these two EVs were 30–40 nm and 20–30 nm in diameter, respec-
tively (Fig. 3B). In addition, this study showed that protein profile is different between whole cell lysate 
(WCL) and EVs, and that protein profile was also different between EVs from the two bacteria (Fig. 3C). 
Moreover, the amount of LPS was higher in P. panacis EVs than P. cedrina EVs (Fig.  3D). These data 
suggest that there is a compositional difference between P. cedrina and P. panacis EVs.
In vitro effects of P. cedrina- and P. panacis-derived EVs on the insulin signaling and glucose 
uptake in skeletal muscle cells. To evaluate the in vitro effect of P. cedrina- and P. panacis-derived 
EVs on the insulin signaling and glucose uptake in skeletal muscle, LPS, P. cedrina EVs, and P. panacis 
EVs were treated to myotubes. This study showed that the insulin-induced expression of pAKT, a sign-
aling molecule of insulin, was abolished by treatment with P. panacis EVs, but unaffected by P. cedrina 
EVs, LPS, or PBS (Fig.  4A). Additionally, the insulin-induced expression of pAKT in adipocytes was 
decreased by treatment with P. panacis EVs or LPS, compared to P. cedrina EVs (Fig. 4B). In contrast, 
the EGF-induced expression of signaling molecules in myotubes was found to be unaffected by the treat-
ment of P. panacis EVs (Fig. S4). These findings suggest that the inhibitory effect of P. panacis EVs on 
transduction pathways is specific to the insulin signaling pathway in insulin-responsive cells. The effect 
of P. panacis EVs on the glucose uptake in skeletal muscle was assessed by using an in vitro glucose 
uptake assay. This study revealed that an insulin-stimulated glucose uptake was blunted in myotubes 
by the treatment with P. panacis EVs, but not with P. cedrina EVs or LPS (Fig.  4C). Moreover, the 
insulin-enhanced GLUT4 translocation in myotubes was inhibited by the treatment of P. panacis EVs, 
but not of P. cedrina EVs or LPS (Fig. 4D). Taken together, these data indicate that P. panacis EVs can 
interfere with insulin signaling in both skeletal muscle and adipose tissue, and also glucose uptake in 
skeletal muscle via the inhibition of GLUT4 translocation.
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In vivo effects of P. cedrina- and P. panacis-derived EVs on the insulin signaling and glucose 
metabolism. To address the in vivo effects of P. cedrina- and P. panacis-derived EVs on the glu-
cose metabolism and insulin sensitivity, LPS, P. cedrina EVs, and P. panacis EVs were administered to 
the mouse stomach. Body weight significantly decreased in mice that received P. panacis EVs or LPS 
compared to P. cedrina EVs (Figure S5). Furthermore, the insulin signaling pathway was blocked at 
the pAKT level in both skeletal muscle and adipose tissue, isolated from P. panacis EVs-received mice, 
when compared to P. cedrina EVs-received mice (Fig. 5A,B). To evaluate whether insulin resistance was 
induced in response to P. panacis EVs, we performed insulin-tolerance test (ITT) and glucose-tolerance 
test (GTT). Blood glucose levels exhibited a blunt response to both glucose loading and insulin injection 
in mice administered with P. panacis EVs vs. P. cedrina EVs and LPS (Fig. 5C,D). Taken together, these 
data imply that P. panacis EVs can impair glucose metabolism by inducing insulin resistance in both 
skeletal muscle and adipose tissue.
Absorption and distribution of P. panacis bacteria and P. panacis-derived EVs after oral 
administration. An in vivo imaging study was performed to evaluate whether gut microbes and 
their secreting EVs were absorbed past the intestinal barriers and moved to target organs, including 
the liver, adipose tissue, and skeletal muscle, after the oral administration of P. panacis bacteria and 
P. panacis-derived EVs. In vivo whole body imaging showed that the bacteria itself did not infiltrate 
through the gut to other organs; however, in mice administered with bacterial EVs, EVs were present in 
the heart and lung areas 5 minutes after the application (Fig. 6A, upper panel). In addition, imaging data 
12 h after the application showed the systemic distribution of EVs, including into the insulin-responsive 
organs, such as the liver, adipose tissue, and skeletal muscle (Fig. 6A). It was further investigated whether 
P. panacis EVs infiltrated the gut barrier and then invaded the target organs. First, we marked a section 
of the large intestine, secured the ends of the sections, and then administered P. panacis bacteria and 
P. panacis EVs. Immunohistochemistry showed that EVs were present in the lamina propria, whereas 
Figure 2. Stool metagenomic analysis indicates that HFD increases the composition of EVs derived 
from phylum Proteobacteria, including Pseudomonas panacis. For all figures, stools were isolated from 
mice after 12 weeks of HFD or RD. (A) Relative abundance (% of total 16S rDNA gene sequences) of gut 
microbes and gut microbe-derived EVs at the phylum level. (B) Principal component analysis (PCA) of 
bacteria and stool EVs. Note the change of EVs composition is greater than that of bacterial composition, 
since EVs composition is separated with principal component 1. (C) Four filters were used to select the most 
essential species, in which EVs were significantly changed after HFD, and then P. cedrina and P. panacis were 
selected. (D) Heatmap plot of stool bacteria and bacterial EVs at the species level. Note that the only species 
occupying more than 1% in at least one sample were included.
www.nature.com/scientificreports/
7Scientific RepoRts | 5:15878 | DOi: 10.1038/srep15878
Figure 3. Characterization of EVs derived from P. cedrina and P. panacis. (A) Transmission electron 
microscopy (TEM) image of P. cedrina EVs and P. panacis EVs. (B) Size of P. cedrina EVs and P. panacis 
EVs. (C) SDS-PAGE analysis of P. cedrina whole cell lysate (WCL), P. cedrina EVs, P. panacis whole cell 
lysate (WCL), and P. panacis EVs. (D) Western blot data (left panel) and ELISA assay (right panel) of lipid A 
in P. cedrina EVs and P. panacis EVs.
Figure 4. P. panacis EVs interfere with insulin signaling in both myotubes and adipocytes, and impair 
glucose uptake in myotubes. (A) Immunoblot analysis of the insulin signaling molecules in L6 myotubes 
after the treatment of LPS, P. cedrina EVs, or P. panacis EVs, with or without insulin (Ins). (B) Werstern blot 
data of the insulin signaling molecules in 3T3-L1 adipocytes after the application of LPS, P. cedrina EVs, 
or P. panacis EVs, with or without Ins. *P < 0.05 vs. P. cedrina EVs. (C) 2-Deoxy[14C]glucose uptake in L6 
myotubes in response to LPS, P. cedrina EVs, or P. panacis EVs, with or without Ins. *P < 0.05. (D) GLUT4 
translocation to the membrane of L6 myotubes after the treatment of LPS, P. cedrina EVs, or P. panacis EVs, 
with or without Ins. *P < 0.05.
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the bacteria were not (Fig.  6B). In addition, two-photon microscopy showed that EVs were present in 
the capillaries of the lamina propria after this application (Fig.  6C). Moreover, immunohistochemical 
staining using P. panacis EVs-reactive polyclonal antibodies revealed that P. panacis EVs, after the oral 
administration of EVs, were present in the liver, adipose tissue and skeletal muscle (Fig.  6D). To sum 
up, these data indicate that bacteria-derived EVs, but no bacteria, infiltrate through the intestinal barrier 
and then distribute into the insulin-responsive tissues.
Discussion
Gut microbes are increasingly being accepted as an environmental factor that affects host metabolism 
and contributes to metabolism-associated pathologic conditions, such as obesity, T2D, and cardiovas-
cular disease. However, the mechanism(s) by which gut microbes cause T2D is still unclear. The data 
presented here showed that the HFD enhanced the release of EVs in the gut from microbes (especially 
phylum Proteobacteria) containing LPS. Furthermore, the composition of EVs from P. panacis, belonging 
to Proteobacteria, was increased by the HFD, and P. panacis EVs caused insulin resistance and glucose 
intolerance in mice.
Recent from the literature highlighted a tight and coordinated connection between gut microbes and 
host metabolism, energy utilization, and storage31. The gut microbial community comprises trillions of 
microorganisms. Cani et al.32 reported that a 4-week HFD increases the composition of LPS-expressing 
Figure 5. P. panacis EVs induce insulin resistance and diabetic phenotypes in RD-fed mice. For all 
figures, LPS, P. cedrina EVs, and P, panacis EVs were administered orally to mice once every 2 days for 4 
weeks. All mice were fed with RD. (A) Phosphorylation of IRS1 and AKT in skeletal muscle after the last 
injection. *P < 0.05. (B) Immunoblot analysis of insulin signaling molecules in the adipose tissue after the 
last application. *P < 0.05. (C) Glucose tolerance test (GTT). GTT was performed in mice 12 h fasting after 
the last application (n = 4 mice per group). *P < 0.05 vs. the other groups. (D) Insulin tolerance test (ITT). 
ITT was performed in mice 6 h fasting after the last application (n = 5 mice per group). *P < 0.05 vs. the 
other groups.
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bacteria in the gut and leads to a two- to three-fold elevation in plasma LPS, a so-called metabolic endo-
toxemia. As a consequence, chronic inflammation induced by low-grade endotoxemia induces insulin 
resistance and glucose intolerance. In addition, the same group provided evidence that antibiotic treat-
ment changes the composition of gut microbiota and reduces fecal and plasma LPS levels33. Consistent 
with these results, our current metagenomic data showed that the composition of EVs-derived from 
LPS-expressing Proteobacteria increased in HFD-fed mice versus RD-fed mice. Moreover, the present 
study revealed that stool EVs from HFD-fed mice induced insulin resistance and glucose intolerance in 
both in vitro and in vivo models. Taking the presence of LPS in EVs into consideration, these data sug-
gest that LPS-expressing EVs derived from gut microbes are key mediators of the development of insulin 
resistance and glucose intolerance promoted by HFDs.
A culture-independent metagenomic approach has provided new insight into the complex interac-
tions between mammalian hosts and gut microbes34. Genetically obese ob/ob mice are hyperphagic as a 
result of a mutation in the gene that encodes the satiety-promoting hormone leptin35. The gut microbiota 
of these mice contains more Firmicutes and fewer Bacteroidetes than their lean wild-type littermates35. 
Similar changes have also been observed in the gut microbiota of obese humans7 and in people whose 
body weight decreased after a Roux-en-Y gastric bypass procedure36. The present study also showed that 
the composition of Firmicutes increased, whereas that of Bacteroidetes decreased, in the gut of HFD-fed 
mice versus RD-fed mice. In summary, these findings indicate that the composition of gut microbes is 
dependent on both genetic and environmental factors.
Figure 6. Absorption and distribution of P. panacis bacteria and P. panacis EVs after oral 
administration. (A) In vivo fluorescent whole body image of P. panacis bacteria and P. panacis EVs 
trafficking in C57BL/6J mice before and after the administration by gavage after overnight fasting (upper 
panel). Lower panel indicates the images of insulin-sensitive organs (liver, adipose tissue, and skeletal 
muscle), which were extracted from mice 12 h after the oral administration. *P < 0.05, **P < 0.01.  
(B) Immunohistochemistry using P. panacis EVs-reactive polyclonal antibodies. Images were taken from the 
large intestine 10 minutes after the surgical injection of P. panacis bacteria and P. panacis EVs.  
P. panacis EVs-reactive antibodies (green dots indicated by white arrows) are seen in the lamina propria 
(LP) of the large intestine. Lu: intestinal lumen. (C) In vivo two-photon image of the large intestine 
before and 10 minutes after the luminal administration of P. panacis EVs. EVs (green dots indicated by 
white arrows) are observed inside the blood vessels in the intestinal lamina propria. Scale bar = 25 μ m. 
(D) Immunohistochemistry using P. panacis EVs-reactive polyclonal antibodies. P. panacis EVs-reactive 
antibodies (green dots indicated by white arrows) are observed in liver, adipose tissue, and skeletal muscle, 
extracted from mice 12 h after the oral administration of P. panacis EVs. Scale bar = 25 μ m.
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Human data indicate that gut microbes are involved in the pathogenesis of T2D8. In the present study, 
we propose that gut microbe-derived EVs play a key role in intracellular communication between gut 
microbes and hosts in glucose metabolism. This study showed that the composition of gut microbe-derived 
EVs significantly differed from that of gut microbes, and that diet change from RD to HFD induced more 
drastic changes in the composition of bacterial EVs versus bacteria. Among gut microbe-derived EVs, 
we found that the composition of P. panacis EVs markedly increased in HFD-fed mice versus RD-fed 
mice. The present data showed that among gut microbe-derived EVs, the P. panacis EVs composition 
markedly increased in HFD-fed mice versus RD-fed mice. Interestingly, this study showed that P. panacis 
EVs induced insulin resistance in both skeletal muscle and adipose tissue, thereby promoting glucose 
intolerance in skeletal muscle. Taken together, these data suggest that gut microbe-derived EVs promoted 
by an HFD can induce T2D via the induction of insulin resistance in insulin-responsive organs.
In the present study, we propose that gut microbe-derived EVs are key communication messengers 
between gut microbes and hosts in the regulation of glucose metabolism. It is increasingly evident that 
gut microbes may shape host metabolic and immune network activities and ultimately influence the 
development of obesity and diabetes. Although much solid evidence indicates that excess energy intake, 
such as HFDs, can affect microbial composition, the mechanism by which gut microbes contribute to 
insulin resistance and thereby T2D is still unclear. Two hypotheses to explain the mechanisms of insu-
lin resistance and T2D are as follows: (1) LPS is taken up with dietary fats in chylomicrons37 or (2) 
LPS reaches the circulation because the gut is more permeable in susceptible mice32. Plasma LPS levels 
rise with increase in fat intake in mice32 and humans38. Animal studies showed that targeted deletion 
of fatty acid synthase in the mouse gut epithelium increases epithelial permeability, thereby increases-
ing pro-inflammatory cytokine levels in the colon and LPS in the serum39. In addition, human stud-
ies demonstrated that subjects with high visceral adiposity and T2D have increased levels of bacterial 
DNA in their blood40.The present study showed that the composition of gut microbe-derived EVs sig-
nificantly differs from that of gut microbes, and diet change from the RD to HFD regimen induced 
more drastic changes in the composition of bacterial EVs versus bacteria. In the present study, we also 
found that gut microbe-derived EVs, but not gut microbes, infiltrated through the intestinal barrier and 
entered the systemic circulation; then, they were distributed to insulin-responsive organs, such as liver, 
adipose tissue, and skeletal muscle. Moreover, this study demonstrated that gut microbe-derived EVs, 
enhanced by the HFD, induced insulin resistance in insulin-responsive organs, thereby impairing glucose 
metabolism. Considering the presence of LPS and DNA in bacterial EVs, these findings suggest that gut 
microbe-derived EVs are important messengers between gut microbes and host glucose metabolism.
The coevolution of gut microbiota and humans has conferred benefits to both the host and the 
bacterial community. However, dramatic changes in modern diets, especially high calorie HFDs, have 
resulted in the disruption of homeostasis between gut microbes and hosts, leading to insulin resistance 
and impaired glucose metabolism. While gut microbes are restricted to the gut, the secreted EVs can 
penetrate through the intestinal barriers and enter the systemic circulation; they are then distributed to 
insulin-responsive organs. The finding that gut microbe-derived EVs directly induce insulin resistance 
while impairing glucose metabolism in both skeletal muscle and adipose tissue provides an important 
clue to understanding the mechanism underlying impaired glucose metabolism in the pathogenesis of 
T2D.
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